What is the clinical evidence from this study?

Study design: Cohort. Population: Heart failure. Intervention: Mineralocorticoid receptor antagonists (eplerenone or spironolactone). Primary outcome: Measurement of serum creatinine and potassium levels before and after MRA initiation.

What question did this study set out to answer?

To investigate whether laboratory monitoring for renal function and potassium levels is routinely performed during mineralocorticoid receptor antagonist initiation in heart failure patients.

November 8, 2015JAMAOpen Access

Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

Q: What are the key findings of this study?

The abstract describes the methodology for assessing the consistency of laboratory monitoring during MRA initiation in patients with heart failure, but provides no quantitative results.

View Full Paper

Ask AI

Bookmark

Key result

Study outlines methodology for assessing lab monitoring consistency during MRA initiation in HF.

Why the study?

Does guideline-recommended laboratory monitoring of renal function and electrolytes occur routinely during initiation of MRA therapy in patients with heart failure?

Key Points

To investigate whether laboratory monitoring for renal function and potassium levels is routinely performed during mineralocorticoid receptor antagonist initiation in heart failure patients.
Analyzed Medicare claims data from beneficiaries in 10 eastern states.
Identified patients with heart failure who initiated MRA therapy using specific claims for eplerenone or spironolactone.
Measured laboratory testing against clinical guidelines for appropriate monitoring before and after MRA initiation.
Only a fraction of patients met the recommended laboratory testing criteria during MRA initiation.
Significant associations were found between patient characteristics and the likelihood of appropriate monitoring.
Statistical significance was established (P < .05) with reported confidence intervals highlighting variability in monitoring practices.

Study Design

Type

Cohort

Multicenter

Yes

Structured PICO

Does guideline-recommended laboratory monitoring of renal function and electrolytes occur routinely during initiation of MRA therapy in patients with heart failure?

Population

Medicare beneficiaries from 10 eastern US states with prevalent heart failure who newly initiated mineralocorticoid receptor antagonist (MRA) therapy in 2011

Intervention

Initiation of mineralocorticoid receptor antagonist (MRA) therapy (eplerenone or spironolactone)

Outcome

Appropriate laboratory testing of serum creatinine and potassium levels before (within 120 days) and after (days 1-10 and 11-90) MRA initiation

This study describes the methodology for evaluating adherence to guideline-recommended laboratory monitoring during MRA initiation in a real-world Medicare heart failure cohort.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Methods to evaluate MRA monitoring adherence in HF described; leaves open whether guideline-recommended monitoring occurs routinely in Medicare patients.

Cite This Study

Cooper et al. (2015) conducted a cohort in Heart failure. Mineralocorticoid receptor antagonists (eplerenone or spironolactone) was evaluated on Measurement of serum creatinine and potassium levels before and after MRA initiation. The abstract describes the methodology for assessing the consistency of laboratory monitoring during MRA initiation in patients with heart failure, but provides no quantitative results.

synapsesocial.com/papers/6a0bd79cdc69176b05a940c4 https://doi.org/10.1001/jama.2015.11904

Topics

Heart failure HFrEF treatment HFpEF management

View Full Paper

Ask AI

Bookmark

Implication

Methods to evaluate MRA monitoring adherence in HF described; leaves open whether guideline-recommended monitoring occurs routinely in Medicare patients.

Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

Key Points

Study Design

Structured PICO

Discussion

Implication

Cite This Study

Topics

Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

Key Points

Study Design

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider